Lomexin is a prescription medication used in women’s health that contains the antifungal agent fenticonazole. It belongs to the class of imidazole antifungals and is formulated as a 600 mg vaginal suppository. In Hong Kong, Lomexin is regulated by the Department of Health and is available only with a medical prescription. The product is designed to treat fungal infections of the vagina and surrounding areas.
Fenticonazole functions by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. Specifically, it blocks the enzyme lanosterol 14α-demethylase, preventing the conversion of lanosterol to ergosterol. Without adequate ergosterol, the fungal cell membrane becomes unstable, leading to leakage of cellular contents and ultimately the death of the fungus. This mechanism addresses the overgrowth of Candida species that cause vulvovaginal candidiasis. The drug is locally absorbed after insertion, providing high concentrations at the site of infection while minimizing systemic exposure.
Lomexin is approved in Hong Kong for the treatment of vulvovaginal candidiasis (yeast infection) caused by Candida species. The medication is indicated for adult women who present with signs such as vaginal itching, burning, abnormal discharge, and irritation. Because the product is formulated for intravaginal use, it delivers the antifungal directly to the affected area, allowing for rapid symptom relief and eradication of the infection.
If your healthcare provider determines that another antifungal class is more appropriate for a specific infection, they may prescribe an alternative therapy.
If any of these conditions apply, consult a healthcare professional before initiating therapy.
These reactions are generally transient and self-limiting. If symptoms persist beyond one week, contact a healthcare provider.
Patients should disclose all prescription drugs, over-the-counter products, herbal supplements, and vitamins before using Lomexin.
This article provides educational information about Lomexin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Fenticonazole is not recommended for use during pregnancy unless a healthcare professional determines that the potential benefit outweighs the risk. Discuss alternative treatments with your provider if you are pregnant.
Most women experience noticeable relief of itching and discharge within 2 to 3 days. Full resolution may take up to a week.
It is advised to avoid sexual intercourse for 24 hours after insertion to allow the medication to remain in place and work effectively.
If the suppository is expelled within the first hour, you may re-insert a new one after consulting a healthcare professional. Do not insert an additional dose without guidance.
Lomexin suppositories contain common excipients such as magnesium stearate and polyethylene glycol. If you have known sensitivities to these substances, discuss alternatives with your clinician.
Concurrent use of other antifungal products is generally unnecessary and may increase irritation. Speak with your provider before combining treatments.
Fenticonazole can modestly inhibit CYP3A4, an enzyme involved in the metabolism of some hormonal contraceptives. While significant reduction in efficacy is unlikely, discuss contraceptive reliability with your healthcare provider.
Store the suppositories at room temperature (below 30 °C) away from humidity and direct sunlight.
Coverage depends on the specific health plan and prescribing physician. Verify with your insurer or the Department of Health for reimbursement details.